Jennifer Stevens
Chief Regulatory Officer · TriSalus Life Sciences, Inc.
- 2025
- Oct 7, 2026
- 3
Summary
Latest filing:
Jennifer Stevens is Chief Regulatory Officer of TriSalus Life Sciences, Inc. (TLSI). 3 SEC Form 4 filings on record going back to 2025, most recently on 7 October 2026. Most recent open-market trade: sold $1K of TLSI on 7 October 2026. Lifetime open-market sales: $16K.
Recent transactions
5The latest 5 SEC Form 4 transactions reported by Jennifer Stevens.
Trading pattern
InsiderAlpha's records for Jennifer Stevens go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Stevens files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael P. Stansky - $3.01M in TLSI purchases and sales in the last 12 months
- Mary T. Szela - $307K in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- David Patience - $32K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Stevens?
Jennifer Stevens is a corporate insider, tracked as Chief Regulatory Officer of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer Stevens submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jennifer Stevens been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($16K) across all tracked filings.